Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT02680132
Brief Summary:
Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Delayed Release Capsule 1 × 40 mg and Nexium 1× 40 mg of AastraZeneca LP, USA. Dosing periods of studies were separated by a washout period of 7 days.
Detailed Description:
An Open Label, Randomized, 2 -Period, 2-Treatment, 2 Sequence, Crossover, Single-Dose Bioequivalence Study of Esomeprazole Delayed Release Capsule 40 mg \[Test Formulation, Torrent Pharmaceutical Ltd., India\]Versus Nexium 40 mg Delayed Release Capsule containing Esomeprazole 40 mg. \[Reference Formulation, AastraZeneca LP, USA\] in Healthy Human Volunteers Under Fed Conditions.
Study:
NCT02680132
Study Brief:
Protocol Section:
NCT02680132